Company Profiles

driven by the PitchBook Platform

Affinimark Technologies

Description

Developer of proprietary medical diagnostic products. The company develops technology for the diagnosis of early-stage prostate cancer and cerebrospinal fluid leak surgery.

2007

Founded

PRIVATE

Status

Later Stage VC

Latest Deal Type

$1.55M

Latest Deal Amount

$3.48M

Total Amount Raised

2

Investors

Description

Developer of proprietary medical diagnostic products. The company develops technology for the diagnosis of early-stage prostate cancer and cerebrospinal fluid leak surgery.

Website:

www.affinimark.com

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Pharmaceuticals

Other Industries

Other Pharmaceuticals and Biotechnology

Primary Office

300 George Street Suite 561 New Haven, CT 06511United States +1 (201) 676-3676
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore Affinimark Technologies's full profile, request a free trial.

Affinimark Technologies Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

Affinimark Technologies Cap Table

Stock# of Shares
Authorized
Par ValueDividend Rate (%)Original
Issue Price
LiquidationLiquidation
Pref. Multiple
Conversion
Price
% Owned

Affinimark Technologies Investors (2)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
Connecticut InnovationsVenture CapitalMinority000 0000000 0000
LaunchCapitalVenture CapitalMinority000 0000000 0000
Connecticut Innovations Venture Capital
LaunchCapital Venture Capital

Affinimark Technologies Executive Team (1)

NameTitleBoard
Seat
Contact
Info
Vincent Pieribone Ph.DPresident, Chief Scientific Officer & Board Member
Vincent Pieribone Ph.D President, Chief Scientific Officer & Board Member

Affinimark Technologies Board Members (4)

NameRepresentingRoleSinceContact
Info
Harry Penner Jr.SelfChairman & Co-Founder000 0000
Kevin CrowleyConnecticut InnovationsManaging Director, Investments000 0000
Konstantine DrakonakisLaunchCapitalDirector000 0000
Vincent Pieribone Ph.DAffinimark TechnologiesPresident, Chief Scientific Officer & Board Member000 0000
Harry Penner Jr. Chairman & Co-Founder Self
Kevin Crowley Managing Director, Investments Connecticut Innovations
Konstantine Drakonakis Director LaunchCapital
Vincent Pieribone Ph.D President, Chief Scientific Officer & Board Member Affinimark Technologies
Request full access to PitchBook